SIOP Asia in Mongolia Was a Great Success
15 Posts Not To Miss From ASCO Breakthrough 2026
Guatemala Officially Enacts New Regulation for Comprehensive Cancer Care
Oncology Community Welcomes Two New FDA Approvals for Breast Cancer
Inside DeepHealth: How RadNet's AI Bet Is Reshaping the Business of Radiology
Gold After Cancer: Summer Olympians Who Returned to Win Medals
Liang Cheng: Transforming the Treatment Landscape of Urothelial Carcinoma
T-Bren Shows Early Activity Across HER2-Positive and HER2-Low Advanced Breast Cancer
Identify low-risk febrile neutropenia patients using the MASCC (Multinational Association for Supportive Care in Cancer) risk index.
Check if YES (0 points), leave unchecked if NO (+5 points)
Check if YES (0 points), leave unchecked if NO (+4 points)
Check if YES (0 points), leave unchecked if NO (+3 points)
Check if YES (+3 points), leave unchecked if NO (0 points)
Check if YES (+2 points), leave unchecked if NO (0 points)
MASCC Risk Index Scoring:
Risk Classification:
